Introduction: Vitamin D is known as an anti-inflammatory, antitumor, and immunemodulating hormone, which plays an important role in common diseases in the geriatric population, such as hypertension and cerebrovascular disorders. Vitamin D deficiency has been linked to various diseases in the literature. However, the association between vitamin D and multiple comorbidities remains unclear due to limited published data. The aim of the present study was to evaluate the association between vitamin D levels and multiple comorbidities in elderly patients.
INTRODUCTION
Comorbidity is described as the occurrence of additional disorders in a patient who has an index disease at a given time point (1) . An index disease is defined as a single disease of interest. Additional disorders are classified according to comorbidity as causality, complication, and coincidence. Causality is an abnormality linked with the pathophysiology of the index disease; complications are impairments due to the treatment of the index disease; and coincidence is the coexistence of any disease that is not related to the index disease (1) . Multimorbidity is defined as the coexistence of two or more chronic diseases of equal importance in the same patient (1, 2) . In the literature, the impact of comorbidities on patients' health has been investigated and associated with poor outcomes, impaired mental functioning, increased percentages of disability and frailty, prolonged hospital stays, risk of adverse drug reactions related to polypharmacy, and higher mortality (1, (3) (4) (5) . The number of comorbidities increases with age, disease duration, and/or disease activity (1, 6) ; thus, there is an increased prevalence of comorbidity in the geriatric population (6) . This association has encouraged physicians to investigate contributors or exacerbators of comorbid conditions (3) . The association between comorbidity and factors, including genes, environment, diet, and exercise, has been stated in the literature (7) (8) (9) . Particularly, vitamin D is one of the most prominent factors accounting for disorders and impairments that contribute to comorbidity.
Vitamin D is a fat-soluble vitamin and hormone that affects not only the musculoskeletal system but also almost all the tissues with vitamin D receptors (10) . Several studies have investigated the association between vitamin D and specific diseases. According to the literature, low vitamin D levels are suggested to be a fundamental risk factor for various disorders, including hypertension, cardiovascular disease, cerebrovascular disease, chronic musculoskeletal pain, decreased physical performance, increased fall risk, and some types of malignancies which are common in the geriatric population (3, (11) (12) (13) . However, studies showing an association between decreased vitamin D levels and comorbidity are very limited in the literature (3).
We hypothesized that low levels of vitamin D may contribute to comorbidities and hence evaluated the association between vitamin D levels and total comorbidity rather than one specific disease in geriatric patients.
MATERIALS AND METHOD

Study population
Geriatric patients (aged ≥65 years) who underwent serum 25(OH)D evaluation during the last 3 months were assessed for eligibility. Of these patients, those who agreed to participate in the study and who met none of the exclusion criteria were included. Exclusion criteria were deafness, cognitive impairment, and unavailability due to other reasons.
The Local Ethics Committee of the University approved the study protocol. All the patients included in the study gave verbal consent.
Vitamin D evaluation
For each patient, serum 25(OH)D levels were tested by high performance liquid chromatography and categorized as sufficient (≥30 ng/ml), insufficient (21-29 ng/ml), and deficient (<20 ng/ml) according to the guidelines of the Endocrine Society (14) .
Comorbidity evaluation
Total comorbidity status was assessed using a self-administered comorbidity questionnaire (15) , with 12 defined medical comorbidities and 3 optional conditions. The questionnaire was completed via a telephonic interview with each participant during a 6-week period. Each interview lasted approximately 10 min. The medical conditions defined in the questionnaire included heart disease, high blood pressure, lung disease, diabetes, ulcer or stomach disease, kidney disease, liver disease, anemia or other blood disease, cancer, depression, osteoarthritis and rheumatoid arthritis, back pain, and other diseases (with 3 open-ended questions). The questionnaire asked not only about the presence of any comorbidity but also whether the patient sought any treatment for the present comorbidity and whether the comorbidity had any impact on the individual's physical function. Each separate comorbidity was scored as 1=present and 0=absent. If a comorbid condition required treatment, an additional point was added. If this comorbidity limited the activity of the patient, another point was added. Thus, each comorbidity could score between 0 and 3 points; the total score ranged between 0 and 36, without the optional conditions, and the maximum score was calculated as 45 points when the open-ended items were also included (15) .
Statistical analysis
SPSS statistical software version 20.0 was used for analysis. The normality of variables was checked using normality tests. Nonparametric tests (MannWhitney U and Kruskal-Wallis tests) were performed to analyze non-normally distributed continuous variables between the groups.
Demographic variables and comorbidity scores were analyzed according to vitamin D subgroups. The difference between the groups was examined using a post-hoc comparison test.
The results were expressed as the mean±standard deviation (SD). P values <0.05 were considered statistically significant. Correlations were tested with the Spearman correlation coefficient. The strength of the correlation was classified as none, very weak, weak-moderate, moderatestrong, and very strong when the correlation coefficient (r s ) values were 0-0.24, 0.25-0.49, 0.50-0.74, and 0.75-1.00, respectively. When the results were analyzed according to vitamin D subgroups (deficient, insufficient, and sufficient), comorbidity scores and BMI were statistically significant among the groups (p< 0.001, p=0.04, respectively) (Table 2; Figure 1 ).
The post-hoc analysis revealed that patients with vitamin D deficiency had higher comorbidity scores than those with insufficiency and sufficiency (p=0.001). The study population was analyzed according to BMI groups (morbidly obese, obese, overweight, normal weight, and underweight), and no significant difference was found in terms of comorbidity scores and vitamin D levels.
A moderate-good negative correlation was found between serum 25(OH)D levels and comorbidity scores (r=−0.503). No correlation was found among the other parameters (Table 3) .
We hypothesized that the comorbidity score would increase as vitamin D levels decreased. Based on the findings of this study, a moderate-good correlation between comorbidity score and vitamin D level was found, which confirmed our hypothesis. 
DISCUSSION
In the present study, we assessed patients' comorbidities using a self-administered comorbidity questionnaire that not only evaluated the comorbid conditions and drugs administered for these conditions but also investigated the ongoing impact of disorders on patients' functionality. The goal of our study was to determine the association of vitamin D levels with multiple comorbidities rather than a single disease or comorbidity.
A negative correlation was found between 25(OH)D levels and comorbidity scores in geriatric patients. In other words, we established the fact that low vitamin D levels are associated with increased comorbid conditions. Vitamin D affects many tissues in the body via several molecular mechanisms. It may also affect the expression of various genes, including those involved in pathophysiological pathways of cell proliferation, differentiation, apoptosis, and angiogenesis, as well as inflammation via these molecular mechanisms. However, it is unclear whether vitamin D modulates the expression of a particular gene in a particular organ under a particular condition (16, 17) . Studies investigating its effects on genes have shown that low levels of vitamin D may be associated with a cause and/or exacerbation of the illnesses. Consequently, decreased vitamin D levels have been linked with several diseases, especially agerelated disorders (3, (11) (12) (13) (16) (17) (18) (19) . Nevertheless, the role of vitamin D in diseases could be viewed as a "chicken or egg" issue; i.e., low vitamin D levels may be a cause of certain disorders or a consequence of disorders and aging (3, 10) . Autier et al. showed an inverse relationship between vitamin D levels and certain diseases, but the efficiency of vitamin D supplementation in diseases was not determined. They suggested that decreased vitamin D level is a marker for ill health rather than a cause or risk factor for certain diseases (3, 20) . Similarly, Meems et al. demonstrated that low levels of vitamin D were associated with a high prevalence of multimorbidity and proposed vitamin D deficiency as a marker for health status (3).
In the current study, we also evaluated the association between comorbidity and demographic variables, such as age and BMI. Comorbidity scores in our study group were not correlated with BMI and were very weakly correlated with age. In a crosssectional study investigating obesity prevalence and health consequences, Eggers et al. showed a positive correlation between BMI and age. In addition, they found that the incidence of certain comorbidities, such as asthma, diabetes, and hypertension, increases with increasing BMI (21) .
According to the literature, the proportion of individuals aged ≥60 years has steadily increased from 8.1% in 1960 to 12% in 2015. This percentage is expected to further increase in the next 30-year period (22, 23) . Comorbid health conditions, such as heart disease, pulmonary disease, diabetes, hypertension, and arthritis, are common in these geriatric patients (24) . Therefore, chronic diseases related to aging have replaced infectious diseases as the main reason for seeking healthcare (22) . Numerous studies have investigated the factors that contribute to disorders in the elderly population, and one of the most important factors believed to impact these diseases is the vitamin D level (11, 16, 25) . However, most studies have only assessed a specific illness and its association with vitamin D levels. Therefore, in the current study, we specifically aimed to evaluate the impact of vitamin D level on patients with multiple comorbidities.
The limitations of the present study are as follows: (i) retrospective nature of our search to predict the target population; and (ii) lack of vitamin D supplementation assessment. The strength of the current study is the confirmation of an inverse association between vitamin D levels and total comorbidity status in geriatric patients. Also, our results provide attention into this association for physicians dealing with geriatric population.
In conclusion, a decreased vitamin D level is associated with increased comorbidity in geriatric patients. Our results suggested that vitamin D deficiency may be a risk factor for comorbidities, particularly in geriatric patients. However, the actual cause of this association remains unclear. Longitudinal studies are warranted to determine whether diseases trigger vitamin D deficiency or low levels of vitamin D cause or exacerbate these diseases.
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